$68.90
-1.01 | -1.44%
-1.01 | -1.44%
Today's Range:
68.71 -
70.10
CELG Avg. Daily Volume:
3,003,900
05/25/12 - 4:00 PM ET
TRADE NOW
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 68.90 |
| 52 Week High | 80.42 |
| 52 Week Low | 51.70 |
| Avg. Daily Vol. (Mil) | 3.00 |
| Beta (3 year) | 0.81 |
| Share Related Items | |
| Mkt Cap (Mil) | 30,350.30 |
| Shares Out (Mil) | 440.50 |
| Float (Mil) | 439.75 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 3.00 |
| Current Ratio | 3.70 |
| LT Debt/ Equity | 0.21 |
| Total Debt / Equity | 0.23 |
| Valuation Ratios | |
| Price Earnings | 21.50 |
| Price/Sales | 6.08 |
| Price/Book | 4.99 |
| Price/Cash Flow | 16.90 |
| Per Share Data | |
| Earnings | 3.21 |
| Sales | 11.33 |
| Book Value | 13.80 |
| Cash Flow | 4.09 |
| Business Summary | |
|---|---|
| Celgene Corporation is a biopharmaceutical company engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. | |
| General Information | |
| 86 Morris Avenue
Summit, NJ 07901 |
|
| www.celgene.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 4460 | |
| CEO: Robert J. Hugin | |
| Short Interest | |
| Current Month (Mil) | 6.08 |
| Previous Month (Mil) | 7.46 |
| Short Interest Ratio (Days) | 1.70 |
| Management Effectiveness | |
| Return on Equity | 24.10 |
| Return on Assets | 14.10 |
| Return on Investments | 19.90 |
| Profitability | |
| Gross Margin | 94.10 |
| EBIT Margin | 33.00 |
| Profit Margin | 29.30 |
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
107.26
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet